Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lipid-only versus triple-phase intradialytic parenteral nutrition in malnourished haemodialysis patients
ACTRN12608000123347Phase 4Not yet recruiting
- Sponsor
- Austin Health
- Start
- Aug 2008
- Modality
- Small Molecules, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Clinoleic, long-chain triglyceride lipid emulsion, Travesol and dextrose in protein-calorie malnutrition (PCM) and chronic kidney disease (CKD) (2 arms), sponsored by Austin Health. Primary endpoint: Complications. Planned start Aug 2008; status: not yet recruiting.
02
Drugs
Clinoleiclong-chain triglyceride lipid emulsionTravesoldextrose
03
Conditions
protein-calorie malnutrition (PCM)chronic kidney disease (CKD)
Beyond the preview
Go deeper on ACTRN12608000123347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000123347.